Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-29

FDA Approved: IVABRADINE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved an Original Application for IVABRADINE from Zydus Pharmaceuticals USA Inc., authorizing a generic IVABRADINE product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

ORIG AP for IVABRADINE (IVABRADINE)